Use AI to fight cancer
Paris-Boston based Owkin, uses machine learning for data driven precision medicine. With an access to images from more than 1 million cases, they can train their Artificial Intelligence models against that huge and relevant data set, in order to find more efficient ways to fight various kinds of cancers. Their collaborative data platform targets the entire value chain, with efficient data collection within hospitals, analytics for oncologists and R&D intelligence for pharmaceutical companies. Founded by two professors, one in oncology and one in data science, Owkin launched in September 2016 and has since gained traction from both pharmaceutical companies and hospitals.
Thomas Clozel, Gilles Wainrib